A host of companies are competing to bring cancer-detecting blood tests to market.
Colorectal cancer is one of the most common cancers in the world and is also one of the leading causes of cancer deaths. It ...
A new blood test for colorectal cancer screening is being implemented in Alabama to improve early detection and reduce deaths from the disease.
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced its Shield™ blood test for colorectal cancer screening (CRC) is now covered for eligible UnitedHealth Group ...